Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Psychotic Depression
NCT00867360Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Aug 2005
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone in major depressive disorder with psychotic features, Bipolar II disorder (BP-II), sponsored by Stanford University. Started Aug 2005; status: terminated.
02
Drugs
mifepristone
03
Conditions
major depressive disorder with psychotic featuresBipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00867360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867360.